## Candidate Studies 

"GSE147194" "GSE147507" "GSE148729"

Same GSE number as SARS-Cov-2

## Studies that fit the criteria

GSE147507: NHBE, A549, A549 transduced with ACE2 & Calu-3 cell lines mock treatment vs. infected with SARS-CoV-2, mock treatment vs. RSV, IAV 

GSE147194: ACE2 library (fragments A-E) variants incubated with RBD for the S1 subunit from Sars-Cov-2. 

GSE148729: Different human cell lines were infected with SARS-CoV-1 and SARS-CoV-2 and harvested at different time points.

## Contrasts

SRP253951: NHBE mock treatment versus infected with SARS-CoV-2 (Series 1): mock;SRX7990866,SRX7990867,SRX7990868: SARS-CoV-2;	SRX7990869,SRX7990870,SRX7990871;

SRP253951: A549 mock treatment versus infected with SARS-CoV-2 (Series 2): mock;SRX7990872,SRX7990873,SRX7990874: SARS-CoV-2;	SRX7990875,SRX7990876,SRX7990877;

SRP253951: A549 mock treatment versus infected with RSV (Series 3): mock;SRX7990878,SRX7990879: RSV;SRX7990880,SRX7990881;

SRP253951: A549 mock treatment versus infected with IAV (Series 4): mock;SRX7990882,SRX7990883: IAV;SRX7990884,SRX7990885;

SRP253951: A549 mock treatment versus infected with SARS-CoV-2 (Series 5): mock;	SRX8089264,SRX8089265,SRX8089266: SARS-COV-2;SRX8089267,SRX8089268,	SRX8089269;

SRP253951: A549 induced with ACE2 mock treatment versus infected with SARS-CoV-2 (Series 6): mock;SRX8089270,SRX8089271,	SRX8089272: SARS-CoV-2;SRX8089273,SRX8089274,SRX8089275;

SRP253951: Calu3 mock treatment versus infected with SARS-CoV-2 (Series 7): mock;SRX8089276,SRX8089277,SRX8089278: SARS-CoV-2;SRX8089279,SRX8089280,SRX8089281;

SRP253951: A549 mock treatment versus infected with RSV (Series 8): mock;SRX8089282,SRX8089283,SRX8089284: RSV;SRX8089285,SRX8089286,SRX8089287;

SRP253951: A549 mock treatment versus infected with HPIV3 (Series 8): mock;SRX8089282,SRX8089283,SRX8089284: HPIV3;SRX8089288,SRX8089289,SRX8089290;

SRP253951: NHBE mock treatment versus infected with IAV (Series 9): mock;SRX8089291,SRX8089292,SRX8089293,SRX8089294: IAV;SRX8089295,SRX8089296,SRX8089297,SRX8089298;

SRP253951: NHBE mock treatment versus infected with IAVdNS1 (Series 9): mock;SRX8089291,SRX8089292,SRX8089293,SRX8089294: IAVdSN1;SRX8089299,SRX8089300,SRX8089301,SRX8089302; 12 hrs (time afer treatment)

SRP253951: NHBE mock treatment versus infected with IFNB (Series 9): mock;SRX8089291,SRX8089292,SRX8089293,SRX8089294: IFNB;SRX8089303,SRX8089304; 4 hrs (time after treatment)

SRP253951: NHBE mock treatment versus infected with IFNB (Series 9): mock;SRX8089291,SRX8089292,SRX8089293,SRX8089294: IFNB;SRX8089305,SRX8089306; 6 hrs (time after treatment)

SRP253951: NHBE mock treatment versus infected with IFNB (Series 9): mock;SRX8089291,SRX8089292,SRX8089293,SRX8089294: IFNB;SRX8089307,SRX8089308; 12 hrs (time after treatment)

SRP253279: ACE2 (fragments A and B) versus high binding to the RBD of the S protein: ACE2;SRX7950376: high binding RBD;SRX7950378,SRX7950380;

SRP253279: ACE2 (fragments A and B) versus low binding to the RBD of the S protein: ACE2;SRX7950376: low binding RBD;SRX7950382,	SRX7950384;

SRP253279: ACE2 (fragments C, D and E) versus high binding to the RBD of the S protein: ACE2;SRX7950377: high binding RBD;SRX7950379,SRX7950381;

SRP253279: ACE2 (fragments C, D and E) versus low binding to the RBD of the S protein: ACE2;SRX7950377: low binding RBD;	SRX7950383,SRX7950385;

SRP253279: high binding to the RBD of the S protein versus low binding to the RBD of the S protein (fragments A and B): high binding RBD;SRX7950378,SRX7950380: low binding RBD;SRX7950382,SRX7950384; 

SRP253279: high binding to the RBD of the S protein versus low binding to the RBD of the S protein (fragments C, D and E):high binding RBD;SRX7950379,SRX7950381: low binding RBD;	SRX7950383,SRX7950385;

SRP256479: H1299 cells mock treatment versus infected with SARS-CoV-1 36 hours post infection: mock;SRX8119839,SRX8119840: SARS-CoV-1;SRX8119847,SRX8119848;

SRP256479: H1299 cells mock treatment versus infected with SARS-CoV-2 36 hours post infection: mock;SRX8119839,SRX8119840: SARS-CoV-2;SRX8119855,SRX8119856;

SRP256479: H1299 cells mock treatment versus infected with SARS-CoV-1 4 hours post infection: mock;SRX8119841,SRX8119842: SARS-CoV-1;SRX8119849,SRX8119850;

SRP256479: H1299 cells mock treatment versus infected with SARS-CoV-2 4 hours post infection: mock;SRX8119841,SRX8119842: SARS-CoV-2;SRX8119857,SRX8119858;

SRP256479: H1299 cells mock treatment (36 and 4 hrs) versus infected with SARS-CoV-1 12 hours post infection:mock;SRX8119839,SRX8119840,SRX8119841,SRX8119842: SARS-CoV-1;SRX8119843,SRX8119844;

SRP256479: H1299 cells mock treatment (36 and 4 hrs) versus infected with SARS-CoV-1 24 hours post infection:mock;SRX8119839,SRX8119840,SRX8119841,SRX8119842: SARS-CoV-1;SRX8119845,SRX8119846;

SRP256479: H1299 cells mock treatment (36 and 4 hrs) versus infected with SARS-CoV-2 12 hours post infection:mock;SRX8119839,SRX8119840,SRX8119841,SRX8119842: SARS-CoV-2;SRX8119851,SRX8119852;

SRP256479: H1299 cells mock treatment (36 and 4 hrs) versus infected with SARS-CoV-2 24 hours post infection:mock;SRX8119839,SRX8119840,SRX8119841,SRX8119842: SARS-CoV-2;SRX8119853,SRX8119854;

SRP256479: H1299 cells mock treatment (36 and 4 hrs) versus untreated (4 hours) :mock;SRX8119839,SRX8119840,SRX8119841,SRX8119842: untreated;SRX8119859,SRX8119860;

SRP256479: Caco2 cells mock treatment versus infected with SARS-CoV-1 24 hours post infection: mock;SRX8119861,SRX8119862: SARS-CoV-1;SRX8119867,SRX8119868;

SRP256479: Caco2 cells mock treatment versus infected with SARS-CoV-1 4 hours post infection: mock;SRX8119863,SRX8119864: SARS-CoV-1;SRX8119869,SRX8119870;

SRP256479: Caco2 cells mock treatment versus infected with SARS-CoV-2 24 hours post infection:mock;SRX8119861,SRX8119862: SARS-CoV-1;SRX8119727,SRX8119728;

SRP256479: Caco2 cells mock treatment versus infected with SARS-CoV-2 4 hours post infection:mock;SRX8119863,SRX8119864: SARS-CoV-2;SRX8119729,SRX8119730;

SRP256479: Caco2 cells mock treatment (4 and 24 hrs) versus infected with SARS-CoV-1 12 hours post infection: mock;SRX8119861,SRX8119862,SRX8119863,SRX8119864: SARS-CoV-1;SRX8119865,SRX8119866;

SRP256479: Caco2 cells mock treatment (4 and 24 hrs) versus untreated (4 hours): mock;SRX8119861,SRX8119862,SRX8119863,SRX8119864: untreated;SRX8119731,SRX8119732;

SRP256479: Caco2 cells mock treatment (4 and 24 hrs) versus infected with SARS-CoV-2 12 hours post infection: mock;SRX8119861,SRX8119862,SRX8119863,SRX8119864: SARS-CoV-2;SRX8119871,SRX8119872;

SRP256479: Series 1 Calu3 cells mock treatment versus untreated (4 hours): mock;SRX8119735,SRX8119736: untreated;SRX8119733,SRX8119734; 

SRP256479: Series 1 Calu3 cells mock treatment versus infected with SARS-CoV-1 4 hours post infection: mock;SRX8119735,SRX8119736: SARS-CoV-1;SRX8119739,SRX8119740;

SRP256479: Series 1 Calu3 cells mock treatment versus infected with SARS-CoV-1 24 hours post infection: mock;SRX8119737,	SRX8119738: SARS-CoV-1;SRX8119743,SRX8119744;

SRP256479: Series 1 Calu3 cells mock treatment (4 and 24 hrs) versus infected with SARS-CoV-1 12 hours post infection: mock;SRX8119735,SRX8119736,SRX8119737,SRX8119738: SARS-CoV-1;SRX8119741,SRX8119742;

SRP256479: Series 1 Calu3 cells mock treatment versus infected with SARS-CoV-2 4 hours post infection: mock;SRX8119735,SRX8119736: SARS-CoV-2;SRX8119745,SRX8119746;

SRP256479: Series 1 Calu3 cells mock treatment versus infected with SARS-CoV-2 24 hours post infection: mock;SRX8119737,	SRX8119738: SARS-CoV-2;SRX8119749,SRX8119750;

SRP256479: Series 1 Calu3 cells mock treatment (4 and 24 hrs) versus infected with SARS-CoV-2 12 hours post infection: mock;SRX8119735,SRX8119736,SRX8119737,SRX8119738: SARS-CoV-2;SRX8119747,SRX8119748;

SRP256479: Series 2 Calu3 cells mock treatment versus infected with SARS-CoV-1 12 hours post infection: mock;SRX8119755,SRX8119756: SARS-CoV-1;SRX8119757,SRX8119758;

SRP256479: Series 2 Calu3 cells mock treatment versus infected with SARS-CoV-2 12 hours post infection: mock;SRX8119755,SRX8119756: SARS-CoV-2;SRX8119759,SRX8119760;

SRP256479: Series 2 Calu3 cells mock treatment versus infected with SARS-CoV-1 4 hours post infection: mock;SRX8119761,SRX8119762: SARS-CoV-1;SRX8119763,SRX8119764;

SRP256479: Series 2 Calu3 cells mock treatment versus infected with SARS-CoV-2 4 hours post infection: mock;SRX8119761,SRX8119762: SARS-CoV-2;SRX8119765,SRX8119766;

SRP256479: Series 2 Calu3 cells mock treatment (4 and 12 hrs) versus infected with SARS-CoV-1 8 hours post infection: mock;SRX8119761,SRX8119762,SRX8119755,SRX8119756: SARS-CoV-1;SRX8119767,SRX8119768;

SRP256479: Series 2 Calu3 cells mock treatment (4 and 12 hrs) versus infected with SARS-CoV-2 8 hours post infection: mock;SRX8119761,SRX8119762,SRX8119755,SRX8119756: SARS-CoV-2;SRX8119769,SRX8119770;

SRP256479: Calu3 cells mock treatment versus infected with SARS-CoV-1 24 hours post infection (smallRNA): mock;SRX8119771,SRX8119772: SARS-CoV-1;SRX8119777,SRX8119778;

SRP256479: Calu3 cells mock treatment versus infected with SARS-CoV-1 4 hours post infection (smallRNA): mock;SRX8119773,SRX8119774: SARS-CoV-1;SRX8119779,SRX8119780;

SRP256479: Calu3 cells mock treatment versus infected with SARS-CoV-2 24 hours post infection (smallRNA): mock;SRX8119771,SRX8119772: SARS-CoV-2;SRX8119783,SRX8119784;

SRP256479: Calu3 cells mock treatment versus infected with SARS-CoV-2 4 hours post infection (smallRNA): mock;SRX8119773,SRX8119774: SARS-CoV-2;SRX8119785,SRX8119786;

SRP256479: Calu3 cells mock treatment versus infected with SARS-CoV-1 24 hours post infection (totalRNA): mock;	SRX8119789,	SRX8119790: SARS-CoV-1;SRX8119795,SRX8119796;

SRP256479: Calu3 cells mock treatment versus infected with SARS-CoV-1 4 hours post infection (totalRNA): mock;SRX8119791,SRX8119792: SARS-CoV-1;SRX8119797,SRX8119798;

SRP256479: Calu3 cells mock treatment versus infected with SARS-CoV-2 24 hours post infection (totalRNA): mock;	SRX8119789,	SRX8119790: SARS-CoV-2;SRX8119801,SRX8119802;

SRP256479: Calu3 cells mock treatment versus infected with SARS-CoV-2 4 hours post infection (totalRNA): mock;SRX8119791,SRX8119792: SARS-CoV-2;SRX8119803,SRX8119804;

SRP256479: DMSO mock infected versus SARS-CoV-2 infected cells: mock infected;SRX8784719,SRX8784720,SRX8784721,SRX8784728,SRX8784729,SRX8784730: SARS-CoV-2 infected;SRX8784722,SRX8784723,SRX8784724,SRX8784731,SRX8784732,SRX8784733;

SRP256479: DMSO mock infected versus 800 nM Onalespib treated SARS-CoV-2 infected cells: mock infected;SRX8784719,SRX8784720,SRX8784721,SRX8784728,SRX8784729,SRX8784730: Onalespib SARS-CoV-2 infected;SRX8784725,SRX8784726,SRX8784727;

SRP256479: DMSO mock infected versus 800 nM 17-AAB treated SARS-CoV-2 infected cells: mock infected;SRX8784719,SRX8784720,SRX8784721,SRX8784728,SRX8784729,SRX8784730: 17-AAB SARS-CoV-2 infected;SRX8784734,SRX8784735,SRX8784736;

SRP256479: DMSO mock infected versus 800 nM Ganetespib treated SARS-CoV-2 infected cells: mock infected;SRX8784719,SRX8784720,SRX8784721,SRX8784728,SRX8784729,SRX8784730: Ganetespib SARS-CoV-2 infected;SRX8784737,SRX8784738,SRX8784739;







